Carol Moreno, MD, PhD, is a Senior Consultant in the Department of Hematology at the Hospital de Sant Pau i Santa Creu, Autonomous University of Barcelona, Barcelona, Spain. She combines clinical work with research activity at the Biomedical Research Institute of Sant Pau. Dr Moreno received her MBBS and her MD degrees from the University of Barcelona. She then conducted post-doctoral research at the Feinstein Institutes for Medical Research, New York, NY.
Dr Moreno currently serves as a board member of the European Research Initiative on CLL (ERIC) and for the Spanish Group on Hematological Malignancies in the Elderly. Furthermore, Dr Moreno is a member of the Scientific Committee of the José Carreras Research Institute and the European Hematology Association (EHA).
Speaking on translational research in CLL
Dr Moreno is actively involved in numerous CLL clinical trials as principal investigator, and is responsible for the clinical and translational program for CLL at the Hospital de la Santa Creu I Sant Pau. Her main research interest is in cellular and molecular mechanisms involved in CLL and in the characterization of residual leukemic cells.